Market Cap: $240.11M
FI
Fate Therapeutics, Inc.
FATE
NASDAQ (NASDAQ Global Market)USD
Market Cap: $240.11M
### Avaí Bio Advances in Cell Therapy Production with Master Cell Bank Avaí Bio, Inc. has recently initiated the production of a Master Cell Bank (MCB) in partnership with Austrianova, marking a signi…
Fate Therapeutics Advances Cell Therapy Pipeline in Fourth Quarter Fate Therapeutics (NASDAQ:FATE) highlights its commitment to innovation within the field of regenerative medicine during its fourth-q…
Fate Therapeutics Advances in Cell-Based Therapies Amid Q4 Financial Report Fate Therapeutics, a leader in innovative cell-based therapies derived from induced pluripotent stem cells (iPSCs), reports…
Oncolytics Biotech Advances Immunotherapy for Pancreatic Cancer Oncolytics Biotech Inc., based in Vancouver, BC, is making significant progress in the field of cancer treatment, specifically through i…
Oncolytics Biotech Targets Breakthrough in Pancreatic Cancer Treatment Oncolytics Biotech Inc., based in Vancouver, is poised to advance its innovative cancer treatment approach with its leading asset…